SCHEMBL5776237

SCHEMBL5776237

CN(CCF)Cc1ccc(C=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.42
CYP2A13 Q16696 1/20 0.42
CARM1 Q86X55 1/20 0.42
PRMT6 Q96LA8 1/20 0.42
PRMT8 Q9NR22 1/20 0.42
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH3A1 P30838 1/20 0.40
ALDH1A3 P47895 1/20 0.40
PYCR1 P32322 3/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SIGMAR1 Q99720 3/20 0.35
HDAC3 O15379 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
TYR P14679 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6206033 0.84 ALDH1A1 (0.46) CYP2A6CYP2A13CARM1PRMT6PRMT8
SCHEMBL8484118 0.78 ACHE (0.52) CYP2A6CARM1PRMT6PRMT8ALDH1A1
SCHEMBL470309 0.77 HRH3 (0.56) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
SCHEMBL5776988 0.76 CARM1 (0.46) CARM1PRMT6PRMT8ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL5778800 0.75 HRH3 (0.54) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
SCHEMBL9875186 0.75 CARM1 (0.70) CARM1PRMT6PRMT8ALDH1A1KDM4E
SCHEMBL3302551 0.74 CYP2A6 (0.55) CYP2A6CYP2A13ALDH1A1KDM4EALDH3A1
SCHEMBL23911919 0.73 CYP2A6 (0.48) CYP2A6CYP2A13ALDH1A1KDM4EALDH3A1
SCHEMBL13480470 0.73 CYP2A6 (0.48) CYP2A6CYP2A13ALDH1A1KDM4EALDH3A1
SCHEMBL20004363 0.73 PYCR1 (0.57) CARM1PRMT6PRMT8ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276433-A1 Hydrazone derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-12-07 US disclosed
EP-1612204-A1 HYDRAZONE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276433-A1 Hydrazone derivative APP, PRNP, HTT CYP2A6 2679/4885CYP2A13 1390/4885CARM1 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.